Here we revealed a critical role of PRMT1 in directly methylating cGAS and blocking cGAS/STING DNA sensing signaling, thus promoting tumor immune evasion, which provides a rationale for PRMT1 as a promising immunotherapeutic target. Here, CGAS is linked to neoplasm.